305 related articles for article (PubMed ID: 31299353)
1. DNA vaccination via RALA nanoparticles in a microneedle delivery system induces a potent immune response against the endogenous prostate cancer stem cell antigen.
Cole G; Ali AA; McErlean E; Mulholland EJ; Short A; McCrudden CM; McCaffrey J; Robson T; Kett VL; Coulter JA; Dunne NJ; Donnelly RF; McCarthy HO
Acta Biomater; 2019 Sep; 96():480-490. PubMed ID: 31299353
[TBL] [Abstract][Full Text] [Related]
2. Immunization with recombinant DNA and modified vaccinia virus Ankara (MVA) vectors delivering PSCA and STEAP1 antigens inhibits prostate cancer progression.
Krupa M; Canamero M; Gomez CE; Najera JL; Gil J; Esteban M
Vaccine; 2011 Feb; 29(7):1504-13. PubMed ID: 21182993
[TBL] [Abstract][Full Text] [Related]
3. DNA vaccination for cervical cancer: Strategic optimisation of RALA mediated gene delivery from a biodegradable microneedle system.
Cole G; Ali AA; McCrudden CM; McBride JW; McCaffrey J; Robson T; Kett VL; Dunne NJ; Donnelly RF; McCarthy HO
Eur J Pharm Biopharm; 2018 Jun; 127():288-297. PubMed ID: 29510205
[TBL] [Abstract][Full Text] [Related]
4. DNA vaccination for cervical cancer; a novel technology platform of RALA mediated gene delivery via polymeric microneedles.
Ali AA; McCrudden CM; McCaffrey J; McBride JW; Cole G; Dunne NJ; Robson T; Kissenpfennig A; Donnelly RF; McCarthy HO
Nanomedicine; 2017 Apr; 13(3):921-932. PubMed ID: 27979747
[TBL] [Abstract][Full Text] [Related]
5. Dissolving microneedles for DNA vaccination: Improving functionality via polymer characterization and RALA complexation.
Cole G; McCaffrey J; Ali AA; McBride JW; McCrudden CM; Vincente-Perez EM; Donnelly RF; McCarthy HO
Hum Vaccin Immunother; 2017 Jan; 13(1):50-62. PubMed ID: 27846370
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
Kim S; Lee JB; Lee GK; Chang J
Prostate; 2009 Jun; 69(9):938-48. PubMed ID: 19267351
[TBL] [Abstract][Full Text] [Related]
7. Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity.
Garcia-Hernandez Mde L; Gray A; Hubby B; Klinger OJ; Kast WM
Cancer Res; 2008 Feb; 68(3):861-9. PubMed ID: 18245488
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cell-directed vaccination with a lentivector encoding PSCA for prostate cancer in mice.
Xiao L; Joo KI; Lim M; Wang P
PLoS One; 2012; 7(11):e48866. PubMed ID: 23139820
[TBL] [Abstract][Full Text] [Related]
9. Bovine papillomavirus prostate cancer antigen virus-like particle vaccines are efficacious in advanced cancers in the TRAMP mouse spontaneous prostate cancer model.
Simons BW; Cannella F; Rowley DT; Viscidi RP
Cancer Immunol Immunother; 2020 Apr; 69(4):641-651. PubMed ID: 32016503
[TBL] [Abstract][Full Text] [Related]
10. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
[TBL] [Abstract][Full Text] [Related]
11. Transcending epithelial and intracellular biological barriers; a prototype DNA delivery device.
McCaffrey J; McCrudden CM; Ali AA; Massey AS; McBride JW; McCrudden MT; Vicente-Perez EM; Coulter JA; Robson T; Donnelly RF; McCarthy HO
J Control Release; 2016 Mar; 226():238-47. PubMed ID: 26883753
[TBL] [Abstract][Full Text] [Related]
12. Electroporation of a nanoparticle-associated DNA vaccine induces higher inflammation and immunity compared to its delivery with microneedle patches in pigs.
Bernelin-Cottet C; Urien C; McCaffrey J; Collins D; Donadei A; McDaid D; Jakob V; Barnier-Quer C; Collin N; Bouguyon E; Bordet E; Barc C; Boulesteix O; Leplat JJ; Blanc F; Contreras V; Bertho N; Moore AC; Schwartz-Cornil I
J Control Release; 2019 Aug; 308():14-28. PubMed ID: 31265882
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Cancer Vaccination by In Situ Nanomicelle-Generating Dissolving Microneedles.
Kim NW; Kim SY; Lee JE; Yin Y; Lee JH; Lim SY; Kim ES; Duong HTT; Kim HK; Kim S; Kim JE; Lee DS; Kim J; Lee MS; Lim YT; Jeong JH
ACS Nano; 2018 Oct; 12(10):9702-9713. PubMed ID: 30141896
[TBL] [Abstract][Full Text] [Related]
15. Smart vaccine delivery based on microneedle arrays decorated with ultra-pH-responsive copolymers for cancer immunotherapy.
Duong HTT; Yin Y; Thambi T; Nguyen TL; Giang Phan VH; Lee MS; Lee JE; Kim J; Jeong JH; Lee DS
Biomaterials; 2018 Dec; 185():13-24. PubMed ID: 30216806
[TBL] [Abstract][Full Text] [Related]
16. A novel DNA/peptide combined vaccine induces PSCA-specific cytotoxic T-lymphocyte responses and suppresses tumor growth in experimental prostate cancer.
Zhang KQ; Yang F; Ye J; Jiang M; Liu Y; Jin FS; Wu YZ
Urology; 2012 Jun; 79(6):1410.e7-13. PubMed ID: 22513035
[TBL] [Abstract][Full Text] [Related]
17. Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery.
Mönkäre J; Pontier M; van Kampen EEM; Du G; Leone M; Romeijn S; Nejadnik MR; O'Mahony C; Slütter B; Jiskoot W; Bouwstra JA
Eur J Pharm Biopharm; 2018 Aug; 129():111-121. PubMed ID: 29803720
[TBL] [Abstract][Full Text] [Related]
18. Construction of a fusion plasmid containing the PSCA gene and cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and its anti-tumor effect in an animal model of prostate cancer.
Mai TJ; Ma R; Li Z; Bi SC
Braz J Med Biol Res; 2016 Oct; 49(11):e5620. PubMed ID: 27783810
[TBL] [Abstract][Full Text] [Related]
19. Ebola Vaccination Using a DNA Vaccine Coated on PLGA-PLL/γPGA Nanoparticles Administered Using a Microneedle Patch.
Yang HW; Ye L; Guo XD; Yang C; Compans RW; Prausnitz MR
Adv Healthc Mater; 2017 Jan; 6(1):. PubMed ID: 28075069
[TBL] [Abstract][Full Text] [Related]
20. Effective humoral immune response from a H1N1 DNA vaccine delivered to the skin by microneedles coated with PLGA-based cationic nanoparticles.
Seok H; Noh JY; Lee DY; Kim SJ; Song CS; Kim YC
J Control Release; 2017 Nov; 265():66-74. PubMed ID: 28434892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
